...
首页> 外文期刊>Materials science & engineering >Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine
【24h】

Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine

机译:乳铁蛋白修饰的脂质纳米载体的设计用于尼莫地平的脑靶向有效递送

获取原文
获取原文并翻译 | 示例
           

摘要

Blood-brain barrier (BBB) was the major obstacle for efficient delivery of therapeutic agents to brain tissue. To overcome this barrier, a novel lactoferrin modified long circulation nanostructured lipid carriers (Lf-NLC) was designed and synthesized for the efficient delivery of neuroprotective agent nimodipine (NMD) to brain tissue. NMD loaded Lf-NLC was optimized to exhibit a small and uniform particle size distribution and high loading content. More interestingly, Lf-NLC showed the excellent neuroprotective effect due to the efficient intracellular delivery NMD, in PC12 based stroke cell model induced by sodium nitroprusside (SNP). Cellular uptake assay indicated that Lf-NLC could be internalized into cytoplasmviaLf-receptor mediated endocytosis pathway.In vivobiodistribution assay demonstrated Lf-NLC could efficiently deliver therapeutic agent to brain tissue, indicating its promising application in brain delivery.
机译:血脑屏障(BBB)是将治疗剂有效递送到脑组织的主要障碍。为了克服这一障碍,设计并合成了一种新型的乳铁蛋白修饰的长循环纳米结构脂质载体(Lf-NLC),用于将神经保护剂尼莫地平(NMD)有效递送至脑组织。优化了装载NMD的Lf-NLC,以显示出较小而均匀的粒径分布和高装载量。更有趣的是,Lf-NLC在硝普钠(SNP)诱导的基于PC12的卒中细胞模型中,由于有效的细胞内递送NMD而显示出优异的神经保护作用。细胞吸收试验表明Lf-NLC可以通过Lf受体介导的内吞途径被内化到细胞质中。体内生物分布试验表明,Lf-NLC可以有效地将治疗剂输送到脑组织,表明其在脑输送中的应用前景广阔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号